affordable health insurance quotes ohio

The HCA IPO could make hospitals a hot investing category. What did its private equity owners do to earn their pay?
it should be interested what change will this make

The timing of Genzyme’s earnings growth is as important as the company’s overall sales when it comes to M&A.
more to read in our archives

Steven Salzberg wrote earlier this week about GlaxoSmithKline’s marketing of fish oil, a supplement, as a drug in the form of its omega-3 fatty acid pill, Lovaza. I took issue with his post, because I think the data for the fish oil omega-3s, DHA and EPA, are pretty strong. (I’ve previously written about this here [...]
does anyone know the real story

An important New Yorker story focuses on the unfortunate reality of rare, expensive treatments: they fail most of the time.
our service is updated everyday, come again

Pivotal Provenge results are published in the New England Journal of Medicine.
does anyone know when this will take effect

Christopher Viehbacher talks about mergers in general, while declining to discuss the one everyone wants to know about.
maybe this will change things

Forget about Grey’s Anatomy and ER when you can go inside a real hospital.
does anyone know when this will take effect

The HCA IPO could make hospitals a hot investing category. What did its private equity owners do to earn their pay?
like our content consider our rss feed!

The timing of Genzyme’s earnings growth is as important as the company’s overall sales when it comes to M&A.
thanks for delivering this story to me

Steven Salzberg wrote earlier this week about GlaxoSmithKline’s marketing of fish oil, a supplement, as a drug in the form of its omega-3 fatty acid pill, Lovaza. I took issue with his post, because I think the data for the fish oil omega-3s, DHA and EPA, are pretty strong. (I’ve previously written about this here [...]
does anyone know the real story